Womens Gentle Laxative
- Product NDC
- 21130-555
- 11-digit product format
- 211300555
- Labeler code
- 21130
- Product ID
- 21130-555_2dede456-ed44-095a-e063-6294a90aff1e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bisacodyl
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- BETTER LIVING BRANDS LLC.
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-07-10
- Substance
- BISACODYL
- Active strength
- 5 mg/1
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 21130-555 | D | Discontinued by firm | 2026-10-16 | ||
| excluded package | package | 21130-555 | 21130-555-01 | D | Discontinued by firm | 2026-10-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 21130-555-01 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 21130-555-01 | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 21130-555-01 | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 21130-555-01 | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 21130-555-01 | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 21130-555-01 | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 21130-555-30 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 21130-555-01 | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 21130-555-30 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 21130-555-01 | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 21130-555-30 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 21130-555-01 | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 21130-555-01 | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 21130-555-01 | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 21130-555-01 | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Womens Gentle Laxative
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BISACODYL | 5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 10X0709Y6I | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 308753 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f2c4ed1a-5aa4-1915-e053-2a95a90a59b6 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 21130-555-30 | 2025-02-12 | C162847 | 48780-1 | 2cef2736-9f9f-d83d-e063-dadaa90ab31f | 151R_Albertsons_21130-555_Bisacodyl USP 5 mg-stimulant laxative |
| 21130-555-30 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-9f9f-d83d-e063-dadaa90ab31f | 151R_Albertsons_21130-555_Bisacodyl USP 5 mg-stimulant laxative |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21130-555-30 | Womens Gentle Laxative | 15 in 1 BLISTER PACK | TABLET | 15 | 3 | |
| 21130-555-30 | Womens Gentle Laxative | 2 in 1 CARTON | TABLET | 2 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Senna Syrup | NATURAL VEGETABLE LAXATIVE | Method Pharmaceuticals | ce83ba78-7e0d-b37f-e053-2995a90a9383 | 2025-10-21 | Warnings | M007 |
| Fiber Lax | CALCIUM POLYCARBOPHIL | PD-Rx Pharmaceuticals, Inc. | 730198a5-b6d9-4fc7-b053-a7c65a93c540 | 2025-10-20 | Warnings | M007 |
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 4694f05b-d927-4e15-9630-a0a1cddb3cbb | 2025-10-16 | Warnings | M007 |
| Glycerin | GLYCERIN | Amerisource Bergen/Good Neighbor Pharmacy | e6a8914f-cfd9-4c72-abaa-22189bf0faef | 2025-10-16 | Warnings | M007 |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 3386fada-6b7f-46fd-e063-6294a90abffc | 2025-10-16 | Warnings | M007 |
| Senna Syrup | SENNA SYRUP | Kesin Pharma Corporation | 360fb98d-c6ad-7bcc-e063-6294a90a9453 | 2025-10-14 | Warnings | M007 |
| Glycerin | GLYCERIN | H E B | 3d0566a1-57a5-6a31-e054-00144ff88e88 | 2025-10-09 | Warnings | M007 |
| SENNA WITH DOCUSATE SODIUM | DOCUSATE SODIUM AND SENNOSIDES | HHH Pharmaceuticals | 2bbb1b99-d43c-40a3-bc53-e18e8394c318 | 2025-10-08 | Warnings | M007 |
| Castor Oil | CASTOR OIL | BIONPHARMA INC. | 3f9728e8-c7a2-6cfb-e063-6394a90a8f1d | 2025-10-06 | Warnings | M007 |
| Sennosides | SENNOSIDES | InvaTech Pharma Solutions LLC | 3de39fbd-29be-fce7-e063-6394a90a67ae | 2025-10-03 | Warnings | M007 |
| Metamucil Therapy for regularity | PSYLLIUM HUSK | The Procter & Gamble Manufacturing Company | a9824f73-5ea2-4a65-a926-3a57561441b8 | 2025-10-01 | Warnings | M007 |
| OneLAX SENNA | SENNA | Atlantic Biologicals Corp. | 40202c76-4273-88fd-e063-6394a90a07b2 | 2025-10-01 | Warnings | M007 |
| Magnesium Citrate | MAGNESIUM CITRATE ORAL SOLUTION | Bionpharma, Inc. | 4019fbd0-fcf9-77a6-e063-6294a90a5ae7 | 2025-09-30 | Warnings | M007 |
| LEADER HYDROCORTISONE WITH ALOE | HYDROCORTISONE | LEADER | 39916470-15bf-4bd0-96e2-b909d68cf9c4 | 2025-09-29 | Warnings | M007 |
| Leader Ready to Use Mineral Oil Laxative | MINERAL OIL | Cardinal Health | b8494d02-8a7d-47b4-80b0-b8ab51b625fd | 2025-09-29 | Warnings | M007 |
| Leader Ready to Use Saline Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Cardinal Health | 1b4f9c28-0547-4922-aa15-990c6fd9dc9f | 2025-09-29 | Warnings | M007 |
| Milk of Magnesia | MAGNESIUM HYDROXIDE | Kesin Pharma Corporation | 3f7cff50-749b-5275-e063-6394a90af407 | 2025-09-23 | Warnings | M007 |
| Stimulant Laxative Plus Stool Softener | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | Bryant Ranch Prepack | 12f613e4-c919-4cc4-a445-eb30039ae45f | 2025-09-18 | Warnings | M007 |
| Saline Laxative | SALINE LAXATIVE | Major Pharmaceuticals | b3758ffe-1bac-4df6-9714-5e33e9d28d90 | 2025-09-16 | Warnings | M007 |
| Gentle Laxative | BISACODYL | BETTER LIVING BRANDS LLC. | f29d57f6-0938-d459-e053-2995a90ad86b | 2025-09-13 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308753 | bisacodyl 5 MG Delayed Release Oral Tablet | PSN | f2c4ed1a-5aa4-1915-e053-2a95a90a59b6 | 3 |
| 308753 | bisacodyl 5 MG Delayed Release Oral Tablet | SCD | f2c4ed1a-5aa4-1915-e053-2a95a90a59b6 | 3 |
| 308753 | bisacodyl 5 MG Enteric Coated Oral Tablet | SY | f2c4ed1a-5aa4-1915-e053-2a95a90a59b6 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 21130-555-30 | 21130055530 | 2 BLISTER PACK in 1 CARTON (21130-555-30) / 15 TABLET in 1 BLISTER PACK | 2 blister pack | 2023-07-10 | No | No | Current |